2013
Error and Bias in the Evaluation of Prescription Opioid Misuse: Should the FDA Regulate Clinical Assessment Tools?
Meltzer E, Hall W, Fins J. Error and Bias in the Evaluation of Prescription Opioid Misuse: Should the FDA Regulate Clinical Assessment Tools? Pain Medicine 2013, 14: 982-987. PMID: 23594383, DOI: 10.1111/pme.12099.Peer-Reviewed Original ResearchConceptsFood and Drug AdministrationClinical assessment toolScreening toolAssessment toolOpioid-related aberrant behaviorsAberrant medication-related behaviorsOpioid-related risksChronic opioid therapyPrescription opioid misusePredictive of addictionMedication-related behaviorsOpioid therapyPain medicationStandardized questionnaireOpioid misuseIdentified patientsAt-riskDrug AdministrationDiagnose illnessAddictive disordersPatientsAberrant behaviorScreeningComprehensive planAddiction
2004
Screening and Cognitive Impairment: Ethics of Forgoing Mammography in Older Women
Raik B, Miller F, Fins J. Screening and Cognitive Impairment: Ethics of Forgoing Mammography in Older Women. Journal Of The American Geriatrics Society 2004, 52: 440-444. PMID: 14962162, DOI: 10.1111/j.1532-5415.2004.52119.x.Peer-Reviewed Original ResearchConceptsCognitively impaired womenCognitive impairmentQuality of lifeDecision-making capacityScreening interventionsMammographic screeningEarly cognitive impairmentLonger life expectancyPatient's capacityVulnerable populationsImpaired womenLife expectancyRisk of undertreatmentMammographyBreast cancerWomenEthical questionsDecision-making processPotential benefitsRiskScreeningRisk/benefit analysisImpairmentOlderDementia